查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1136906

全球顱內支架市場-2022-2029

Global Intracranial Stents Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

全球顱內支架市場受到人口快速老齡化、腦動脈瘤和慢性神經系統疾病（如高血壓、膽固醇和糖尿病）發病率增加、自膨式支架領域技術進步和支架靈活性的推動。由於性能力的提高。

慢性神經疾病患病率上升推動市場增長

根據腦動脈瘤基金會 (BAF) 的數據，腦動脈瘤每年導致約 500,000 人死亡，並且在女性中更為常見。 BAF 估計動脈瘤在 35-60 歲年齡段更常見，如果一級親屬（例如父母、兄弟姐妹或孩子）患有動脈瘤，則動脈瘤的發病率會增加。患有結締組織病和多囊腎病等遺傳疾病的患者通常也會患上腦動脈瘤。

根據 2020 年 9 月《神經病學前沿》雜誌，美國 IIH 的年度全國發病率為 1.15/100,000。 2020 年 8 月發表在同一期刊上的另一項研究發現，科威特等中東國家的 IIH 發病率相似，但高於西方地區。據估計，每 10 萬人中有 2 人。根據《神經病學、神經外科和精神病學雜誌》的報導，中國人對 ICAS 的耐受性可能不如白種人，而且發病年齡更早。它代表了 ICAD 的最晚期階段，並且是眾所周知的短暫性腦缺血發作 (TIA) 和缺血性中風的原因。

預計會阻礙市場增長的並發症風險

顱內支架製造商和醫療保健服務提供商面臨嚴重的預算限制，以及由於支架遷移並發症和術後腦出血風險而導致外科醫生接受度低，預計將在預測期內影響市場。被認為會抑制

COVID-19 影響分析

COVID-19 大流行對顱內支架市場產生了負面影響，包括選擇性手術減少、供應鏈中斷和運營挑戰。例如，Stryker 報告銷售額下降 3.6%，淨利潤下降 23.2%。儘管 Covid 爆發帶來了挑戰，但該公司通過 2020 年 11 月收購 Wright Medical 顯著增強了其開發能力、產品和服務線以及市場影響力。美敦力神經血管淨銷售額受到缺血性中風產品的穩定增長和出血性中風產品的適度增長的推動。出血性中風主要在 Pipeline Flex 分流系統中繼續增長，部分被第四季度由於與大流行相關的手術中斷而導致的下降所抵消。

行業分析

全球顱內支架市場是基於波特五力、監管分析、供應鏈分析和定價分析、報銷政策、技術進步、PEST分析等多種行業因素對市場的深入分析。提供。

全球顱內支架市場報告包含大約 45 多個市場數據表、40 多個數字和 180 頁。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

  • 按產品類型劃分的市場細分
  • 按疾病劃分的市場細分
  • 按設計劃分的市場細分
  • 按應用劃分的市場細分
  • 最終用戶的市場細分
  • 按地區劃分的市場細分

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 神經系統慢性疾病增加
    • 約束因素
      • 並發症風險
    • 影響分析

第五章行業分析

  • 波特五力分析
  • 供應鏈分析
  • PEST 分析
  • 定價分析
  • 監管分析
  • 保險報銷分析
  • 未滿足的需求分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 自膨式支架
  • 球囊擴張支架
  • 支架輔助線圈栓塞

第八章疾病適應症

  • 腦動脈瘤
  • 顱內狹窄

第 9 章設計

  • 打開單元格
  • 封閉單元格

第 10 章按應用程序

  • 神經型
  • 紙牌
  • 企業
  • Leoplus
  • 翼展

第 11 章，最終用戶

  • 醫院
  • 門診手術中心
  • 診所
  • 其他

第 12 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 13 章競爭格局

  • 競爭場景
  • 市場定位/市場份額分析
  • 併購分析

第 14 章公司簡介

  • 美敦力公司
    • 公司簡介
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Penumbra, Inc
  • Stryker Corporation
  • Boston Scientific Corporation Inc
  • Terumo Corporation
  • Cook Medical
  • DePuy Synthes
  • Balt Extrusion S.A
  • MicroPort Scientific Corporation
  • Abbott Laboratories

第 15 章全球顱內支架市場-DataM

簡介目錄
Product Code: DMMD929

Market Overview

The Intracranial Stents Market was valued US$ 360 million in 2021 and is estimated to reach US$ 702.8 million by 2029, growing at a CAGR of 8.98% during the forecast period (2022-2029).

An intracranial stent is a tubular structure that is placed inside the canal, duct, or blood vessel. They are used for the treatment of intracranial stenosis. Intracranial stenosis is caused by narrowing of the blood vessels or blood clots due to the building up of fats, plaque, and other substances in the blood vessels. This condition causes stroke in the carotid artery in the neck or an intracranial artery.

Market Dynamics

The global intracranial stents market is growing due to the rapid rise in the geriatric population, an increase in the incidence of chronic neurological diseases like brain aneurysm and hypertension, cholesterol, and diabetes, and technical advances in the field of self-expanding stents and improvement in flexibility of the stents.

Rising prevalence of chronic neurological diseases drives the growth of the market

According to the Brain Aneurysm Foundation (BAF), a brain aneurysm causes around 500,000 deaths annually and is more common among women. BAF estimates that aneurysms are predominant in the age group of 35-60 years, and their occurrence increases if a first-degree relative like a parent, sibling, or child has aneurysms. In addition, patients with genetic disorders like connective tissue disorders or polycystic kidney disease usually suffer from cerebral aneurysms.

According to September 2020 in Frontiers in Neurology Journal, the annual national incidence for IIH was 1.15 out of 100,000 in the United States. Also, per another study published in August 2020 in the same journal, the incidence of IIH was similar in Middle Eastern countries, such as Kuwait and other regions, but was higher than in western areas. It was estimated at 2 per 100,000. According to the Journal of Neurology, Neurosurgery and Psychiatry, Chinese were more unsafe to ICAS than Caucasians, with an earlier age of onset. It represents the most advanced stage of ICAD and is a common cause of Transient Ischemic Attack (TIA) and ischemic stroke.

Risks of complications are expected to hamper the market growth

Tight budgetary constraints faced by intracranial stents manufacturers and healthcare service providers and fewer acceptances among surgeons due to the risks of complications regarding the stent movement and bleeding in the brain after surgery are going to restrain the market in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic led to a reduced number of elective surgeries, supply chain hurdles, operational challenges, and other adverse impacts on the market for intracranial stents. Stryker, for example, reported a 3.6% decline in sales while net earnings decreased by 23.2%. Despite the challenges posed by the covid outbreak, the company significantly strengthened its development capabilities, product and service lines, and the market reaches through the acquisition of Wright Medical in November 2020. Medtronic's net neurovascular sales were driven by the constant growth of Ischemic stroke products and modest growth in hemorrhagic stroke products. Hemorrhagic stroke saw continuous growth, mainly with the Pipeline Flex flow diversion system, partly offset by a decline in the fourth quarter owing to procedural suspensions caused by the pandemic.

Industry Analysis

The global intracranial stents market provides in-depth analysis of the market based on various industry factors such as porter's five forces, regulatory analysis, supply chain analysis and pricing analysis, reimbursement policies, technological advancements, PEST analysis.

Segment Analysis

The self-expanding stents segment is expected to hold the largest market share in global intracranial stents market

The self-expanding stents segment accounts for the highest market due to the increasing geriatric population, incidence of intracranial disorders and launch of innovative products will boost segment growth. For instance, in May 2019, Stryker's Neuroform Atlas stent received premarket approval from the U.S. FDA. It comprises a self-expanding stent intended for use with detachable metal embolization coils. In addition, the APOLLO Intracranial Stent System from MicroPort Scientific Corporation is explicitly intended for improving cerebral artery lumen diameter in patients with atherosclerosis in intracranial vessels. This stent system comprises a balloon-expandable stent. Product advancements and initiatives by market players are expected to drive the market for intracranial stents.

Geographical Analysis

North America region holds the largest market share in the global intracranial stents market

North America was held a dominant position in the global intracranial stents market in 2021. High prevalence of neurological diseases coupled with the presence of sophisticated healthcare infrastructure and rising per capita healthcare makes North America the largest revenue generator in the market. According to the Centers for Disease Control and Prevention (CDC), neurological disorders such as epilepsy, Alzheimer's, strokes, multiple sclerosis, and migraines are the 5th leading cause of death in the U.S., affecting around 100 million people every year. This large patient pool costs the nation 800 billion annually, including the cost of health care services, medications, and lost productivity.

This large volume of patients with stroke requires intracranial stenting. As per the American Heart Association, in the year 2020, atherosclerotic stenosis was identified as the primary cause of around 700,000 strokes.

Competitive Landscape

The intracranial stents market is highly competitive, owing to big market players in the industry. The key intracranial stents players which are contributing to the growth of the global market include Penumbra, Inc., Medtronic plc, Stryker Corporation, Boston Scientific Corporation Inc., Terumo Corporation, Cook Medical, DePuy Synthes, Balt Extrusion S.A., MicroPort Scientific Corporation, and Abbott Laboratories among others. The major players are adopting new product development and expansion strategies for global growth in the intracranial stents market. In March 2020, In India, Sree Chitra Tirunal Institute for Medical Sciences and Technology, developed an intracranial flow diverter stent for treating brain aneurysms.

Global Intracranial Stents Market - Key Companies to Watch

Medtronic Plc:

Overview: Medtronic plc is an American company that operates in U.S. and manufactures and markets medical device headquarters in Minneapolis, US. It is operational in around 140 countries and 90,000 people are employed there.

Product Portfolio: Pipeline Flex embolization device is the device indicated for the endovascular treatment of adults (22 years of age or older) with certain wide-necked intracranial aneurysms (IAs) in the internal carotid artery from the petrous to the superior hypophyseal segments.

The global intracranial stents market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product Type
  • 3.2. Market Snippet by Disease Indication
  • 3.3. Market Snippet by Design
  • 3.4. Market Snippet by Uses
  • 3.5. Market Snippet by End-User
  • 3.6. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising prevalence of chronic neurological diseases
    • 4.1.2. Restraint
      • 4.1.2.1. Risks of complications
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. PEST Analysis
  • 5.4. Pricing Analysis
  • 5.5. Regulatory Analysis
  • 5.6. Reimbursement Analysis
  • 5.7. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. Self-expanding stents*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Balloon expanding stents
  • 7.4. Stent-assisted coil embolization

8. By Disease Indication

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication Segment
    • 8.1.2. Market Attractiveness Index, By Disease Indication Segment
  • 8.2. Brain aneurysm*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Intracranial stenosis

9. By Design

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design Segment
    • 9.1.2. Market Attractiveness Index, By Design Segment
  • 9.2. Open-cell
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Closed-cell

10. By Uses

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses Segment
    • 10.1.2. Market Attractiveness Index, By Uses Segment
  • 10.2. Neuroform*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Solitaire
  • 10.4. Enterprise
  • 10.5. Leo Plus
  • 10.6. Wingspan

11. By End User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 11.1.2. Market Attractiveness Index, By End User Segment
  • 11.2. Hospitals*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 11.3. Ambulatory Surgical Centers
  • 11.4. Clinics
  • 11.5. Others

12. By Region

  • 12.1. Introduction
  • 12.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 12.3. Market Attractiveness Index, By Region
  • 12.4. North America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
    • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses
    • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. US.
      • 12.4.8.2. Canada
      • 12.4.8.3. Mexico
  • 12.5. Europe
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
    • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses
    • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. Germany
      • 12.5.8.2. U.K.
      • 12.5.8.3. France
      • 12.5.8.4. Italy
      • 12.5.8.5. Spain
      • 12.5.8.6. Rest of Europe
  • 12.6. South America
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
    • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses
    • 12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.6.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.6.8.1. Brazil
      • 12.6.8.2. Argentina
      • 12.6.8.3. Rest of South America
  • 12.7. Asia Pacific
    • 12.7.1. Introduction
    • 12.7.2. Key Region-Specific Dynamics
    • 12.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
    • 12.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 12.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses
    • 12.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.7.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.7.8.1. China
      • 12.7.8.2. India
      • 12.7.8.3. Japan
      • 12.7.8.4. Australia
      • 12.7.8.5. Rest of Asia Pacific
  • 12.8. Middle East and Africa
    • 12.8.1. Introduction
    • 12.8.2. Key Region-Specific Dynamics
    • 12.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
    • 12.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 12.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses
    • 12.8.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. Medtronic plc
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. Penumbra, Inc
  • 14.3. Stryker Corporation
  • 14.4. Boston Scientific Corporation Inc
  • 14.5. Terumo Corporation
  • 14.6. Cook Medical
  • 14.7. DePuy Synthes
  • 14.8. Balt Extrusion S.A
  • 14.9. MicroPort Scientific Corporation
  • 14.10. Abbott Laboratories

LIST NOT EXHAUSTIVE

15. Global Intracranial Stents Market - DataM

  • 15.1. Appendix
  • 15.2. About Us and Services
  • 15.3. Contact Us